Stay updated on MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety

Sign up to get notified when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.
Latest website image capture
Clouds background image

Latest updates to the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page

  1. Check
    6 days ago
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    0.8%
    Check dated 2025-07-11T07:09:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant announcement regarding the modernization of ClinicalTrials.gov data ingest has been deleted.
    Difference
    0.9%
    Check dated 2025-07-04T03:44:37.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The expected modernization of the ClinicalTrials.gov data ingest has been postponed from June 2025 to July 2025, and the revision version has been updated from v2.16.2 to v2.16.4.
    Difference
    1.0%
    Check dated 2025-06-19T19:19:04.000Z thumbnail image
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:01:22.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:47:51.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The page has removed a citation regarding the results of two phase 3 trials on Tildrakizumab for chronic plaque psoriasis, which may impact the credibility and comprehensiveness of the content related to this treatment.
    Difference
    0.2%
    Check dated 2025-05-14T20:58:53.000Z thumbnail image

Stay in the know with updates to MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety

Enter your email address, and we'll notify you when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.